At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected
Only in the crazy sector of metabolic medicines can 32% revenue growth be considered a disappointment. That’s how much Eli ...
Sunday, March 9, 2025
Tag: JPM
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.